Cogstate LTD (ASX: CGS)
Sector: Health Care
Market cap: A$596M (as of 2 Nov 2026)
Cogstate Ltd (ASX:CGS) is the neuroscience company optimising brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 20 Aug 2026 | State Street Australia Ltd ACF Australian Ethical Investment Limited | Decrease | 8.0% → 6.7% | Filing ↗ |
| 3 July 2026 | State Street Australia Ltd ACF Australian Ethical Investment Limited | Decrease | 9.05% → 8.0% | Filing ↗ |
| 3 Nov 2025 | Anacacia Pty Limited | Exit | — | Filing ↗ |
| 17 Oct 2025 | Brad O’Connor | Increase | — | Filing ↗ |
| 24 Sept 2025 | Anacacia Pty Limited | Decrease | 8.200% → 6.800% | Filing ↗ |
Director trades — on-market
Cash and runway
| Metric | Value | As of | Source |
|---|---|---|---|
| Cash | A$30.8B | 30 Sept 2022 | Filing ↗ |
Latest cash figure is from 30 Sept 2022 and may predate a later quarterly filing.
Ask about CGS in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CGS raised money in the last year, and at what discount?
- What was CGS's latest cash position and runway?
Loading CGS…